Comparative analysis of humoral immune response upon the three first vaccines applied in Argentina: IgG production and neutralizing capacity against SARS-CoV-2

The population that has not received a SARS-CoV-2 vaccine is at high risk for infection whereas vaccination prevents COVID-19 severe disease, hospitalization, and death. In Argentina, to date, more than 50 million doses of vaccines against SARS-CoV-2 have been administered. The three main vaccines a...

Descripción completa

Detalles Bibliográficos
Autores principales: Giai, Constanza, Salassa, Betiana Nebaí, Zarelli, Valeria Eugenia, Bello, Oscar Daniel, Vanrell, María Cristina, Ojeda, Diego Sebastian, Gamarnik, Andrea, Colombo, María Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113595/
https://www.ncbi.nlm.nih.gov/pubmed/37090429
http://dx.doi.org/10.1016/j.heliyon.2023.e15211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113595/
https://www.ncbi.nlm.nih.gov/pubmed/37090429
http://dx.doi.org/10.1016/j.heliyon.2023.e15211

Ejemplares similares